RLBCX
Price
$35.41
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
WMBLX
Price
$13.04
Change
-$0.10 (-0.76%)
Updated
Jun 13 closing price
Net Assets
93.49M
Interact to see
Advertisement

RLBCX vs WMBLX

Header iconRLBCX vs WMBLX Comparison
Open Charts RLBCX vs WMBLXBanner chart's image
American Funds American Balanced R3
Price$35.41
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
WesMark Balanced
Price$13.04
Change-$0.10 (-0.76%)
VolumeN/A
Net Assets93.49M
RLBCX vs WMBLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLBCX vs. WMBLX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBCX is a Buy and WMBLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 244B vs. WMBLX (93.5M). WMBLX pays higher dividends than RLBCX: WMBLX (1.87) vs RLBCX (1.63). RLBCX was incepted earlier than WMBLX: RLBCX (23 years) vs WMBLX (27 years). WMBLX (1.30) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. WMBLX (12.00). RLBCX has a lower initial minimum investment than WMBLX: RLBCX (250) vs WMBLX (1000). RLBCX annual gain was more profitable for investors over the last year : 4.94 vs. WMBLX (-2.55). RLBCX return over 5 years is better than : 36.51 vs. WMBLX (15.56).
RLBCXWMBLXRLBCX / WMBLX
Total Expense Ratio0.891.3068%
Annual Report Gross Expense Ratio0.891.3068%
Fund Existence23 years27 years-
Gain YTD4.2940.474906%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets244B93.5M260,963%
Annual Yield % from dividends1.631.8788%
Returns for 1 year4.94-2.55-193%
Returns for 3 years31.547.16441%
Returns for 5 years36.5115.56235%
Returns for 10 years54.9921.51256%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
NOVA0.22N/A
N/A
Sunnova Energy International
XTNT0.62-0.03
-4.23%
Xtant Medical Holdings
FND73.63-3.40
-4.41%
Floor & Decor Holdings
EZGO0.36-0.02
-4.65%
EZGO Technologies Ltd